agilon health, inc. (NYSE:AGL) Insider Benjamin Kornitzer Sells 5,396 Shares

agilon health, inc. (NYSE:AGLGet Rating) insider Benjamin Kornitzer sold 5,396 shares of the company’s stock in a transaction that occurred on Friday, January 20th. The shares were sold at an average price of $19.92, for a total value of $107,488.32. Following the transaction, the insider now directly owns 10,426 shares of the company’s stock, valued at approximately $207,685.92. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Benjamin Kornitzer also recently made the following trade(s):

  • On Thursday, January 5th, Benjamin Kornitzer sold 2,698 shares of agilon health stock. The stock was sold at an average price of $15.51, for a total value of $41,845.98.
  • On Friday, December 16th, Benjamin Kornitzer sold 5,398 shares of agilon health stock. The stock was sold at an average price of $16.82, for a total transaction of $90,794.36.
  • On Monday, December 5th, Benjamin Kornitzer sold 5,398 shares of agilon health stock. The shares were sold at an average price of $17.80, for a total value of $96,084.40.

agilon health Stock Up 0.4 %

agilon health stock traded up $0.09 during mid-day trading on Monday, reaching $20.50. The stock had a trading volume of 1,399,780 shares, compared to its average volume of 2,164,691. agilon health, inc. has a one year low of $14.36 and a one year high of $28.36. The company has a 50-day moving average price of $17.39 and a two-hundred day moving average price of $20.92. The company has a market capitalization of $8.44 billion, a price-to-earnings ratio of -78.50 and a beta of 0.80. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.48 and a quick ratio of 2.48.

agilon health (NYSE:AGLGet Rating) last issued its earnings results on Thursday, November 3rd. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.02). The firm had revenue of $694.86 million during the quarter, compared to the consensus estimate of $651.24 million. agilon health had a negative return on equity of 9.31% and a negative net margin of 4.30%. On average, analysts expect that agilon health, inc. will post -0.21 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on AGL. The Goldman Sachs Group reduced their price target on agilon health from $38.00 to $34.00 and set a “buy” rating on the stock in a research note on Tuesday, November 15th. Stifel Nicolaus began coverage on shares of agilon health in a research note on Thursday, December 8th. They issued a “buy” rating and a $23.00 price target for the company. SVB Leerink lowered their price target on shares of agilon health from $33.00 to $30.00 and set an “outperform” rating for the company in a research report on Friday, November 4th. Finally, Wells Fargo & Company cut their price objective on shares of agilon health from $28.00 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, November 15th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $28.38.

Hedge Funds Weigh In On agilon health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Level Financial Advisors Inc. bought a new stake in shares of agilon health in the second quarter worth approximately $25,000. IFP Advisors Inc grew its position in agilon health by 236.3% in the 3rd quarter. IFP Advisors Inc now owns 1,231 shares of the company’s stock worth $38,000 after purchasing an additional 865 shares during the period. Van ECK Associates Corp bought a new stake in agilon health in the 3rd quarter worth approximately $45,000. Lazard Asset Management LLC purchased a new stake in agilon health during the 1st quarter valued at $69,000. Finally, Vigilant Capital Management LLC bought a new position in shares of agilon health during the 3rd quarter valued at $102,000.

About agilon health

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Further Reading

Insider Buying and Selling by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.